哈尔滨医科大学学报
哈爾濱醫科大學學報
합이빈의과대학학보
JOURNAL OF HARBIN MEDICAL UNIVERSITY
2015年
2期
162-164
,共3页
淋巴瘤%CD64指数%流式细胞术
淋巴瘤%CD64指數%流式細胞術
림파류%CD64지수%류식세포술
lymphoma%CD64 index%flow cytometry
目的:评价中性粒细胞CD64指数在淋巴瘤患者化疗后合并细菌感染中检测及早期诊断的价值。方法选取106例淋巴瘤患者,根据临床症状、体征和微生物学检测结果分为细菌感染组(51例)和非细菌感染组(55例),健康对照组30例,应用流式细胞仪检测中性粒细胞表面CD64指数,同时检测血清C反应蛋白和白细胞数( WBC)。结果化疗后合并细菌感染的淋巴瘤患者组CD64指数显著高于非感染组及健康对照组,差异均具有显著的统计学意义( P<0.01)。通过ROC曲线分析,CD64指数对化疗后合并细菌感染的诊断优于CRP和WBC计数。结论 CD64指数可作为淋巴瘤化疗后合并细菌感染的早期诊断、鉴别诊断的指标,指导抗菌药物应用。
目的:評價中性粒細胞CD64指數在淋巴瘤患者化療後閤併細菌感染中檢測及早期診斷的價值。方法選取106例淋巴瘤患者,根據臨床癥狀、體徵和微生物學檢測結果分為細菌感染組(51例)和非細菌感染組(55例),健康對照組30例,應用流式細胞儀檢測中性粒細胞錶麵CD64指數,同時檢測血清C反應蛋白和白細胞數( WBC)。結果化療後閤併細菌感染的淋巴瘤患者組CD64指數顯著高于非感染組及健康對照組,差異均具有顯著的統計學意義( P<0.01)。通過ROC麯線分析,CD64指數對化療後閤併細菌感染的診斷優于CRP和WBC計數。結論 CD64指數可作為淋巴瘤化療後閤併細菌感染的早期診斷、鑒彆診斷的指標,指導抗菌藥物應用。
목적:평개중성립세포CD64지수재림파류환자화료후합병세균감염중검측급조기진단적개치。방법선취106례림파류환자,근거림상증상、체정화미생물학검측결과분위세균감염조(51례)화비세균감염조(55례),건강대조조30례,응용류식세포의검측중성립세포표면CD64지수,동시검측혈청C반응단백화백세포수( WBC)。결과화료후합병세균감염적림파류환자조CD64지수현저고우비감염조급건강대조조,차이균구유현저적통계학의의( P<0.01)。통과ROC곡선분석,CD64지수대화료후합병세균감염적진단우우CRP화WBC계수。결론 CD64지수가작위림파류화료후합병세균감염적조기진단、감별진단적지표,지도항균약물응용。
Objective To explore the early diagnosis value of neutrophil CD 64 index in lym-phoma patients with infection after chemotherapy .Methods One hundred and six patients with lymphoma were divided into infection group ( n=51 ) and un-infection group ( n=55 ) ac-cording to symptoms and microbiological test results , and 30 healthy person were as control . Levels of CD64, CRP and WBC were measured .Results Expressions of CD64 in infection group were higher than those in control group ( P<0.05 ) .ROC curve showed that CD 64 index was superior to CRP and WBC in diagnosis of infection of lymphoma patients after chemothera-py.Conclusion The CD64 index can be used as a marker of early diagnosis and differential diagnosis in lymphoma patients after chemotherapy complicated with infection , and guide the application of anti-bacterial drugs .